(Q28273083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Targeting survivin in cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Nadia Zaffaroni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Marzia Pennati

1

1 reference

ORCID Public Data File 2021

language of work or name

English

0 references

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

463-476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

Cancer genes and the pathways they control

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517/14728222.12.4.463

The inhibitors of apoptosis (IAPs) as cancer targets

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

IAPs--the ubiquitin connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

HBXIP functions as a cofactor of survivin in apoptosis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin study: an update of "what is the next wave"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

The case for survivin as a regulator of microtubule dynamics and cell-death decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

The case for Survivin as mitotic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Chromosomal passengers: the four-dimensional regulation of mitotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Chromosome alignment and segregation regulated by ubiquitination of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Cell division and cell survival in the absence of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin and molecular pathogenesis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Mitosis-independent survivin gene expression in vivo and regulation by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

An IAP-IAP complex inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Separating the anti-apoptotic and mitotic roles of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Regulation of survivin function by Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin splice variants regulate the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Forced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin, a cancer target with an emerging role in normal adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Role of the Survivin gene in pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Expression of survivin during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin expression in the stomach: implications for mucosal integrity and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin, versatile modulation of cell division and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin: a promising tumor biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Nuclear or cytoplasmic expression of survivin: what is the significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

A p34(cdc2) survival checkpoint in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin mediates resistance to antiandrogen therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin as a target for new anticancer interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Targeting survivin in cancer therapy: fulfilled promises and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin is required for stable checkpoint activation in taxol-treated HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Rational design of shepherdin, a novel anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Cancer gene therapy using a survivin mutant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Identification of novel survivin-derived CTL epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

Small-Molecule Targeting of Heat Shock Protein 90 Chaperone Function: Rational Identification of a New Anticancer Lead

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.12.4.463

10.1517/14728222.12.4.463

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18348682%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference